Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of YZJ-4729 tartrate injection for postoperative analgesia after orthopedic surgery
CTR20262692Phase 3Active
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of YZJ-4729 in postoperative pain, sponsored by Shanghai Haiyan Pharmaceutical Technology Co., Ltd.. Started Jul 2026; status: active.
02
Drugs
YZJ-4729
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20262692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262692.